Rfer_2991 is commercially available as a lyophilized powder (Creative BioMart Cat.#: RFL28263RF) with the following specifications:
| Parameter | Details |
|---|---|
| Expression System | E. coli |
| Tag | N-terminal 6xHis |
| Purity | >90% (SDS-PAGE) |
| Storage | -20°C/-80°C in Tris/PBS buffer with 6% trehalose (pH 8.0); avoid freeze-thaw cycles |
| Reconstitution | 0.1–1.0 mg/mL in sterile water; glycerol (5–50%) recommended for long-term storage |
The protein is not intended for human use and is strictly for research purposes .
Rfer_2991 is primarily used in:
Structural Biology: Crystallization or cryo-EM studies to resolve its transmembrane architecture.
Functional Assays: Investigating its role in ion transport, redox reactions, or stress responses.
Membrane Protein Interaction Studies: Partner identification via pull-down assays leveraging its His tag .
Functional Unknowns: The UPF0761 domain’s role remains uncharacterized.
Biophysical Challenges: Hydrophobic TMDs may complicate solubilization and crystallization.
Evolutionary Context: Comparative studies with homologs in Rhodoferax antarcticus or R. ferrireducens could clarify its ecological adaptations .
KEGG: rfr:Rfer_2991
STRING: 338969.Rfer_2991
Recombinant Rhodoferax ferrireducens UPF0761 membrane protein Rfer_2991 is a full-length (416 amino acids) membrane protein originally derived from the bacterium Rhodoferax ferrireducens strain T118 (ATCC BAA-621 / DSM 15236). When produced recombinantly, it is typically expressed in E. coli with an N-terminal His-tag to facilitate purification and downstream applications . The protein belongs to the UPF0761 family of membrane proteins, a group that remains functionally uncharacterized despite having predicted structural features. The UniProt accession number for this protein is Q21U51, which can be used to access additional sequence and annotation information across biological databases .
The three-dimensional structure of Rfer_2991 has been computationally modeled using AlphaFold (model ID: AF-Q21U51-F1), which was released in AlphaFold DB on December 9, 2021, and last modified on September 30, 2022 . This model has a global confidence score (pLDDT) of 77.4, placing it in the "Confident" category (70 < pLDDT ≤ 90) . It is important to note that this is a computed structure model without experimental verification. The confidence score breakdown shows variable reliability across different regions of the protein:
Very high confidence regions (pLDDT > 90): Limited portions of the structure
Confident regions (70 < pLDDT ≤ 90): Most of the structured domains
Low confidence regions (50 < pLDDT ≤ 70): Some connecting regions
Very low confidence regions (pLDDT ≤ 50): Likely unstructured in isolation
Researchers should consider these confidence metrics when designing experiments that rely on structural information .
Based on established protocols for recombinant membrane proteins, Rfer_2991 requires specific handling conditions to maintain structural integrity and functionality:
Storage conditions: Store at -20°C/-80°C upon receipt, with aliquoting recommended for multiple use scenarios .
Buffer composition: Typically supplied in Tris/PBS-based buffer with 6% trehalose at pH 8.0, or alternatively in Tris-based buffer with 50% glycerol optimized for protein stability .
Reconstitution protocol:
Stability considerations: Avoid repeated freeze-thaw cycles; working aliquots can be stored at 4°C for up to one week .
These handling procedures are critical for maintaining protein integrity, especially for membrane proteins that are prone to aggregation and denaturation.
When designing experiments with Rfer_2991, researchers should apply the six key concepts of experimental design while addressing the specific challenges of membrane protein research:
Clearly defined variables: Establish distinct independent variables (e.g., buffer conditions, temperature, ligand concentrations) and dependent variables (e.g., binding affinity, structural changes, functional activity) .
Appropriate controls: Include both positive controls (well-characterized membrane proteins) and negative controls (non-membrane proteins or buffer-only samples) to validate experimental outcomes .
Random assignment: When testing multiple conditions, randomly assign samples to different treatment groups to minimize systematic bias, particularly important in binding studies or functional assays .
Environmental consistency: Maintain consistent laboratory conditions to prevent confounding variables from affecting membrane protein stability, which is especially sensitive to temperature and pH fluctuations .
Replication strategy: Design with sufficient biological and technical replicates to account for the inherent variability in membrane protein experiments, typically requiring 3-5 independent preparations .
Control for confounding variables: Address factors such as detergent concentration, lipid composition, and metal ion presence that specifically affect membrane protein behavior .
For Rfer_2991 specifically, researchers should consider its predicted membrane localization when designing experimental procedures to maintain native-like conditions throughout purification and analysis .
Based on conventional approaches for recombinant membrane proteins similar to Rfer_2991, the following expression and purification strategies are recommended:
Expression System Selection:
E. coli-based expression: The documented system for Rfer_2991 is E. coli with an N-terminal His-tag . This system offers cost-effectiveness and scalability, though proper membrane insertion may be challenging.
Alternative expression hosts: For improved membrane insertion and post-translational modifications, consider:
Insect cell systems (Sf9, High Five)
Mammalian expression systems (HEK293, CHO)
Cell-free expression systems with supplied lipids or nanodiscs
Purification Protocol Design:
Membrane extraction: Use a two-step extraction with mild detergents (e.g., DDM, LMNG, or CHAPS) to solubilize the membrane fraction while preserving protein structure
Affinity chromatography: Utilize the N-terminal His-tag with Ni-NTA or TALON resin for initial purification
Secondary purification: Apply size exclusion chromatography (SEC) or ion exchange chromatography for higher purity
Detergent exchange: Consider exchanging to a more stable detergent or reconstituting into nanodiscs or liposomes for functional studies
Quality Control Checkpoints:
SDS-PAGE and Western blot to confirm identity and purity (>90% recommended)
Circular dichroism to verify secondary structure integrity
Analytical SEC to assess monodispersity
Mass spectrometry to confirm exact molecular weight and post-translational modifications
Membrane localization and topology studies for Rfer_2991 require specialized techniques beyond standard protein analysis:
Computational prediction validation:
Experimental topology mapping:
Cysteine scanning mutagenesis with membrane-impermeable sulfhydryl reagents
Protease protection assays with reconstituted protein
Fluorescence-based techniques with strategically placed fluorophores
EPR spectroscopy with site-directed spin labeling
Cellular localization studies:
Confocal microscopy with fluorescently tagged constructs
Cell fractionation followed by Western blotting
Surface biotinylation assays
Proteoliposome reconstitution to assess functional orientation
Interaction analysis:
Proximity labeling techniques (BioID, APEX)
Crosslinking mass spectrometry to identify interaction partners
Native mass spectrometry for intact membrane protein complexes
These approaches provide complementary data to build a comprehensive understanding of Rfer_2991's membrane integration and potential functional interactions.
Since Rfer_2991 belongs to the UPF0761 family of uncharacterized membrane proteins, determining its function requires a multi-faceted approach:
Comparative genomics analysis:
Analyze gene neighborhood in Rhodoferax ferrireducens genome
Identify conserved domains across homologous proteins
Perform phylogenetic analysis to identify functional clues from evolutionary relationships
Structural homology assessment:
Biochemical characterization:
Screen for enzyme activity with various substrates
Assess binding to potential ligands using thermal shift assays
Perform transport assays if a transporter function is suspected
Analyze lipid binding preferences through lipidomic approaches
Genetic manipulation studies:
Generate knockout or knockdown systems in Rhodoferax ferrireducens
Perform complementation studies with mutant variants
Utilize heterologous expression to identify phenotypic changes
Interaction networks:
Identify protein interaction partners through pull-down assays
Perform bacterial two-hybrid screening
Use proteomics approaches to identify co-regulated proteins
This systematic characterization workflow moves from in silico predictions to in vitro and in vivo validation, providing multiple lines of evidence for functional assignment.
The structural and functional analysis of Rfer_2991 can be enhanced through these specialized biophysical techniques:
Advanced structural analysis:
X-ray crystallography (challenging for membrane proteins but provides high resolution)
Cryo-electron microscopy (particularly suitable for membrane proteins)
Solid-state NMR for studying dynamics in membrane environments
Small-angle X-ray scattering (SAXS) for solution conformation
Dynamics and conformational studies:
Membrane interaction characterization:
Neutron reflectometry to determine membrane insertion depth
Atomic force microscopy for topography and mechanical properties
Fluorescence correlation spectroscopy for diffusion properties
Isothermal titration calorimetry for binding energetics
Functional assessment techniques:
Electrophysiology (patch clamp) if ion channel activity is suspected
Fluorescence-based transport assays with reconstituted proteoliposomes
Surface plasmon resonance for interaction kinetics
Microscale thermophoresis for binding studies
When designing these experiments, researchers should consider the moderate confidence level (pLDDT 77.4) of the available structural model and validate structural predictions experimentally .
Membrane proteins like Rfer_2991 present specific challenges that require systematic troubleshooting approaches:
Low expression yields:
Optimize codon usage for expression host
Test different promoter strengths and induction conditions
Evaluate alternative expression hosts (yeast, insect cells)
Consider fusion partners that enhance membrane protein expression (MBP, SUMO)
Protein aggregation:
Screen multiple detergents and lipid compositions
Optimize buffer conditions (pH, ionic strength, stabilizing additives)
Reduce expression temperature to slow folding
Add chemical chaperones during expression
Purification difficulties:
Adjust detergent concentration during extraction and purification
Incorporate stabilizing ligands if known
Implement gradient elution protocols
Consider on-column detergent exchange
Functional assay development:
Validate protein folding before functional testing
Test multiple reconstitution methods (liposomes, nanodiscs)
Establish positive controls with related proteins
Consider native tissue sources for comparative studies
Storage stability issues:
Evaluate cryoprotectant additives beyond standard glycerol
Test lyophilization with suitable excipients
Investigate detergent/lipid mixtures that enhance stability
Consider chemical modification approaches to reduce aggregation propensity
These troubleshooting strategies should be implemented systematically, changing one parameter at a time while maintaining appropriate controls.
Ensuring data validity when working with challenging membrane proteins like Rfer_2991 requires rigorous validation strategies:
Protein quality assessment:
Confirm protein identity through mass spectrometry
Verify purity using multiple methods (SDS-PAGE, analytical SEC)
Assess homogeneity using dynamic light scattering
Validate correct folding through circular dichroism or thermal shift assays
Experimental design validation:
Statistical analysis approaches:
Apply appropriate statistical tests based on data distribution
Control for multiple comparisons when testing numerous conditions
Implement mixed-effects models when dealing with batch variations
Report effect sizes in addition to p-values
Reproducibility considerations:
Perform independent biological replicates (minimum n=3)
Use different protein preparations to account for batch effects
Test critical findings under varying conditions to establish robustness
Validate key results using orthogonal methodologies
Data reporting standards:
Document all experimental conditions comprehensively
Report negative and inconsistent results
Provide raw data when possible
Clearly distinguish between technical and biological replication
These validation strategies align with best practices in experimental research design while addressing the specific challenges of membrane protein biochemistry .
For convenient reference, the key properties of Recombinant Rhodoferax ferrireducens UPF0761 membrane protein Rfer_2991 are summarized in the following table:
This consolidated reference table provides essential information for experimental planning and protocol development when working with Rfer_2991.